본문 바로가기
KERD
논문KCI 등재

폐경기 여성에서 나이관련황반변성과 여성 호르몬 요인과의 관계: 제5기 국민건강영양조사 자료

Female Hormone Factors Associated with Age-related Macular Degeneration in Menopausal Korean Women: KNHANES V

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

목적: 폐경기 여성에서 나이관련황반변성과 여성 호르몬 요인과의 관계를 밝히고자 한다. 대상과 방법: 4,479명의 제5기 국민건강영양조사를 완료한 45세 이상의 폐경기 여성을 대상으로 나이관련황반변성 환자와 건강한 사람, 초기와 후기 나이관련황반변성 환자군을 구분하여 내인성 및 외인성 여성호르몬 인자와 나이관련황반변성의 관계에 대해 알아보았다. 결과: 전체 연구 대상자는 4,479명 중 나이관련황반변성군은 516명이었고, 정상군은 3,963명이었다. 두 군 간의 위험도 분석에서 나이를 제외한 다른 요인은 통계적 의미를 보이지 않았다. 전체 나이관련황반변성 516명 중 초기 나이관련황반변성군은 488명이었고, 후기 나이관련황반변성군은 28명이었으며, 피임약 사용기간이 길어질수록 후기 나이관련황반변성의 위험도가 초기 나이관련황반변성보다 1.013배 높았고(p=0.024, 95% confidence interval [CI]: 1.002-1.024), 출산력이 많을수록 후기 나이관련황반변성의 위험도가 초기 나이관련황반변성보다 0.672배로 낮았다(p=0.006, 95% CI: 0.506-0.893). 결론: 내인성 및 외인성 여성 호르몬 요인은 나이관련황반변성의 경과에 영향을 미칠 수 있다.

Abstract

Purpose: To investigate whether endogenous and exogenous female hormone exposures were associated with risks for age-related macular degeneration (AMD) in postmenopausal women. Methods: This study included 4,479 postmenopausal females aged 45 years and older who completed the Korea National Health and Nutrition Examination Survey (KNHANES) V. The participants were divided into 4 groups: subjects with AMD, subjects without AMD, subjects with early AMD, and subjects with late AMD. Variables associated with endogenous and exogenous female hormone exposures were analyzed. Results: Among the 4,479 participants, 516 were found to have AMD and 3,963 were normal. There was no significant difference between the AMD and normal groups execpt for age in the risk analysis. Of the total 516 AMD participants, 488 had early AMD and 28 had late AMD. Women with AMD who had used oral contraceptives longer in the past had significantly higher odds of late AMD than early AMD (odds ratio [OR] = 1.013, 95% confidence interval [CI]: 1.002-1.024). Increasing number of children was also associated with decreased odds of late AMD (OR = 0.672, 95% CI: 0.506-0.893). Conclusions: These findings suggest that exposure to endogenous and exogenous female hormones may influence the risk of AMD progression.

참고문헌 (34)

  1. Mangione CM, "Influence of age-related maculopathy on visual functioning and health-related quality of life", Am J Ophthalmol, 128, pp.45~53 (1999)
  2. Klein R, "Prevalence of age-related maculopathy:The Beaver Dam Eye Study", Ophthalmology, 99, pp.933~943 (1992)
  3. 박규형, "국내의 나이관련황반변성에 대한 기초역학조사", 대한안과학회지, 51(4), pp.516~523 (2010), 대한안과학회
  4. Smith W, "Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study", Aust N Z J Ophthalmol, 25(Suppl 1), pp.S13~S15 (1997)
  5. Snow KK, "Do age-related macular degeneration and cardiovascular disease share common antecedents?", Ophthalmic Epidemiol, 6, pp.125~143 (1996)
  6. Friedman E, "The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration", Am J Ophthalmol, 130, pp.658~663 (2000)
  7. Kaarniranta K, "Estrogen signalling in the pathogenesis of age-related macular degeneration", Curr Eye Res, 40, pp.226~233 (2015)
  8. Klein BE, "Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study", Trans Am Ophthalmol Soc, 92, pp.289~295 (1994)
  9. Age-Related Eye Disease Study Research Group, "Risk factors associated with age-related macular degeneration: A case-control study in the age-related eye disease study: age-related eye disease study report number 3", Ophthalmology, 107, pp.2224~2232 (2000)
  10. Klein BE, "Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study", Am J Ophthalmol, 130, pp.322~326 (2000)
  11. Snow KK, "Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women", Am J Ophthalmol, 134, pp.842~848 (2002)
  12. Abramov Y, "The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women", Menopause, 11, pp.62~68 (2004)
  13. Edwards DR, "Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms", Invest Ophthalmol Vis Sci, 51, pp.1873~1879 (2010)
  14. Freeman EE, "Hormone replacement therapy, reproductive factors, and age-related macular degeneration:the Salisbury Eye Evaluation Project", Ophthalmic Epidemiol, 12, pp.37~45 (2005)
  15. Haan MN, "Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study", Arch Ophthalmol, 124, pp.988~992 (2006)
  16. Feskanich D, "Menopausal and reproductive factors and risk of age-related macular degeneration", Arch Ophthalmol, 126, pp.519~524 (2008)
  17. 임형택, "호르몬 대체요법과 안 질환: 제4기 국민건강영양조사자료", 대한안과학회지, 53(10), pp.1445~1450 (2012), 대한안과학회[DOI]
  18. 윤경철, "Prevalence of Eye Diseases in South Korea: Data from the Korea National Health and Nutrition Examination Survey 2008-2009", Korean Journal of Ophthalmology, 25(6), pp.421~433 (2011), 대한안과학회
  19. Park SJ, "Age-related macular degeneration:prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011", Ophthalmology, 121, pp.1756~1765 (2014)
  20. Centers for Disease Control and Prevention, "Cigarette smoking among adults--United States, 1992, and changes in the definition of current cigarette smoking", MMWR Morb Mortal Wkly Rep, 43, pp.342~346 (1994)
  21. Muñoz B1, "Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study", Arch Ophthalmol, 118, pp.819~825 (2000)
  22. Klein BE, "Incidence of age-related cataract: The Beaver Dam Eye Study", Arch Ophthalmol, 116, pp.219~225 (1998)
  23. Ogueta SB, "Estrogen receptor in the human eye", Invest Ophthalmol Vis Sci, 40, pp.1906~1911 (1999)
  24. Munaut C, "Presence of oestrogen receptor type beta in human retina", Br J Ophthalmol, 85, pp.877~882 (2001)
  25. Subbiah MT, "Antioxidant potential of specific estrogens on lipid peroxidation", J Clin endocrinol Metab, 77, pp.1095~1097 (1993)
  26. Calaf i Alsina J, "Benefits of hormone replacement therapy--overview and update", Int J Fertil Womens Med 1997;42 Suppl, 42(Suppl 2), pp.329~346 (1997)
  27. Subbiah MT, "Mechanisms of cardioprotection by estrogens", Proc Soc Exp Biol Med, 217, pp.23~29 (1998)
  28. Kovacs WJ, "Textbook of endocrine physiology", pp.264~291 (2012), Oxford University Press
  29. 조현희, "호르몬 피임약의 사용: 내과적 질환이 있는 경우", Obstetrics & Gynecology Science, 50(11), pp.1455~1467 (2007), 대한산부인과학회
  30. Seddon JM, "Association between C-reactive protein and age-related macular degeneration", JAMA, 291, pp.704~710 (2004)
  31. Seddon JM, "Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers", Arch Ophthalmol, 123, pp.774~782 (2005)
  32. Cushman M, "Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen", Progestin Interventions (PEPI) Study, 1999, pp.100, 717~722
  33. Kwok S, "Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy", Clin Endocrinol (Oxf), 61, pp.760~767 (2004)
  34. Vessey MP, "Oral Contraception and eye disease: findings in two large cohort studies", Br J Ophthalmol, 82, pp.538~542 (1998)

관련 논문AI추천

이 간행물의 다른 논문 (14건)